The management of Peyronie's disease
Open Access
- 19 December 2003
- journal article
- review article
- Published by Wiley in BJU International
- Vol. 93 (2), 208-215
- https://doi.org/10.1111/j.1464-410x.2004.04587.x
Abstract
Peyronie's disease has no known cause; recent understanding of the molecular mechanisms involved and the development of an animal model will aid the medical management of early disease. The medical management of chronic disease is futile as the delicate tunical architecture cannot regenerate. Surgical correction of the penile deformity is required in a minority of patients, and a choice lies between a Nesbit operation and a plaque incision and venous patch in patients who are concerned with penile shortening.Keywords
This publication has 87 references indexed in Scilit:
- Peyronie's disease cell culture models: phenotypic, genotypic and functional analysesInternational Journal Of Impotence Research, 2002
- Clinical presentations of Peyronie's diseaseInternational Journal Of Impotence Research, 2002
- Intralesional interferon-alpha-2b for the treatment of Peyronie's diseaseInternational Journal Of Impotence Research, 2002
- LONG-TERM FOLLOWUP OF TREATMENT FOR PEYRONIE???S DISEASE: MODELING THE PENIS OVER AN INFLATABLE PENILE PROSTHESISJournal of Urology, 2001
- Induratio penis plastica - Extrakorporale piezoelektrische Stoßwellentherapie (EPT) als neuer TherapieansatzAktuelle Urologie, 1998
- Out-patient Assessment of Penile CurvatureBritish Journal of Urology, 1987
- ULTRASONIC THERAPY IN PEYRONIE'S DISEASEBritish Journal of Urology, 1967
- THE USE OF DIMETHYL SULFOXIDE IN THE TREATMENT OF GENITOURINARY DISORDERSAnnals of the New York Academy of Sciences, 1967
- PLASTIC INDURATION OF THE PENIS: PEYRONIE'S DISEASEBritish Journal of Urology, 1963
- THE USE OF TOCOPHEROLS IN THE TREATMENT OF PEYRONIE'S DISEASEAnnals of the New York Academy of Sciences, 1949